MyFinsight
Home
Blog
About
Cash and cash
equivalents
$420,078K
(149.24%↑ Y/Y)
Marketable securities
$362,498K
(-9.81%↓ Y/Y)
Receivable from
collaboration partner
$13,416K
Prepaid expenses and
other current assets
$7,790K
(-10.44%↓ Y/Y)
Contract asset
$3,366K
(-85.59%↓ Y/Y)
Total current assets
$807,148K
(33.96%↑ Y/Y)
Marketable securities -
noncurrent
$66,875K
(-34.75%↓ Y/Y)
Operating lease
right-of-use asset
$6,946K
(-19.13%↓ Y/Y)
Property and equipment,
net
$3,456K
(-15.87%↓ Y/Y)
Other non-current
assets
$832K
Restricted cash -
noncurrent
$287K
(-1.03%↓ Y/Y)
Total assets
$885,544K
(23.33%↑ Y/Y)
Total liabilities and
stockholders' equity
$885,544K
(23.33%↑ Y/Y)
Total stockholders'
equity
$841,543K
(25.98%↑ Y/Y)
Total liabilities
$44,001K
(-11.98%↓ Y/Y)
Accumulated deficit
-$304,039K
(21.43%↑ Y/Y)
Accumulated other
comprehensive (loss) income
-$828K
(-5420.00%↓ Y/Y)
Additional paid-in capital
$1,146,409K
(8.67%↑ Y/Y)
Total current
liabilities
$37,181K
(4.71%↑ Y/Y)
Operating lease liability
- noncurrent
$6,820K
(-25.10%↓ Y/Y)
Common stock, 0.00001
par value,...
$1K
(0.00%↑ Y/Y)
Accrued expenses and
other payables
$21,667K
(40.72%↑ Y/Y)
Deferred revenue
$9,659K
(-34.24%↓ Y/Y)
Accounts payable
$3,459K
(6.46%↑ Y/Y)
Operating lease liability
$2,396K
(10.26%↑ Y/Y)
Back
Back
Balance Sheet
Protagonist Therapeutics, Inc (PTGX)
Protagonist Therapeutics, Inc (PTGX)
source: myfinsight.com